241 related articles for article (PubMed ID: 11394632)
1. Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.
Mishra A; Wong L; Jonklaas J
Endocrine; 2001 Mar; 14(2):159-64. PubMed ID: 11394632
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate.
Cömlekçi A; Biberoglu S; Hekimsoy Z; Okan I; Pişkin O; Sekeroglu B; Alakavuklar M
Intern Med; 1998 Apr; 37(4):396-7. PubMed ID: 9630201
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
Stuckey BG; Lim EM; Kent GN; Ward LC; Gutteridge DH
J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843
[TBL] [Abstract][Full Text] [Related]
4. Hypocalcemia following pamidronate administration for bone metastases of solid tumor: three clinical case reports.
Champallou C; Basuyau JP; Veyret C; Chinet P; Debled M; Chevrier A; Grongnet MH; Brunelle P
J Pain Symptom Manage; 2003 Feb; 25(2):185-90. PubMed ID: 12590034
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature.
Maalouf NM; Heller HJ; Odvina CV; Kim PJ; Sakhaee K
Endocr Pract; 2006; 12(1):48-53. PubMed ID: 16524863
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate-induced hypocalcemia associated with vitamin D deficiency in a patient with advanced cancer.
Broadbent A; Glare P; Crawford B
Am J Hosp Palliat Care; 2005; 22(5):382-4. PubMed ID: 16225361
[TBL] [Abstract][Full Text] [Related]
7. Prolonged hypocalcaemia after pamidronate infusion in Riedel's thyroiditis associated hypoparathyroidism.
Boumans D; de Vries PA; Rikken NE; Laverman GD
Neth J Med; 2013 Oct; 71(8):442-3. PubMed ID: 24127509
[No Abstract] [Full Text] [Related]
8. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism.
Milman S; Epstein EJ
Endocr Pract; 2011; 17(1):104-7. PubMed ID: 21041166
[TBL] [Abstract][Full Text] [Related]
10. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
11. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
Sims EC; Rogers PB; Besser GM; Plowman PN
Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
[TBL] [Abstract][Full Text] [Related]
12. Pamidronate, hypocalcemia, and calcium and vitamin D supplementation.
Altundag O; Altundag K
J Clin Oncol; 2004 May; 22(10):2035; author reply 2035. PubMed ID: 15143101
[No Abstract] [Full Text] [Related]
13. Hypocalcemic disorders.
Bove-Fenderson E; Mannstadt M
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):639-656. PubMed ID: 30449546
[TBL] [Abstract][Full Text] [Related]
14. Hypocalcemia Secondary to Zoledronate Therapy in a Patient With Low Vitamin D Level.
Epperla N; Pathak R
WMJ; 2015 Aug; 114(4):163-6; quiz 167. PubMed ID: 26436186
[TBL] [Abstract][Full Text] [Related]
15. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.
Kananen K; Volin L; Laitinen K; Alfthan H; Ruutu T; Välimäki MJ
J Clin Endocrinol Metab; 2005 Jul; 90(7):3877-85. PubMed ID: 15797959
[TBL] [Abstract][Full Text] [Related]
16. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.
Altundag O; Altundag K; Selim Silay Y; Gunduz M; Demircan K; Gullu I
Med Hypotheses; 2004; 63(6):1010-3. PubMed ID: 15504568
[TBL] [Abstract][Full Text] [Related]
17. Oral calcium chloride in hypoparathyroidism refractory to massive doses of calcium carbonate and vitamin D.
Komindr S; Schmidt LW; Palmieri GM
Am J Med Sci; 1989 Sep; 298(3):182-4. PubMed ID: 2801754
[TBL] [Abstract][Full Text] [Related]
18. Organic anxiety in a woman with breast cancer receiving denosumab.
Lin KF; Chen KH; Huang WL
Gen Hosp Psychiatry; 2015; 37(2):192.e7-8. PubMed ID: 25772947
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Kraj M; Pogłód R; Maj S; Pawlikowski J; Sokołowska U; Szczepanik J
Acta Pol Pharm; 2002; 59(6):478-82. PubMed ID: 12669777
[TBL] [Abstract][Full Text] [Related]
20. Severe and prolonged hypocalcemia after a single dose of denosumab for metastatic breast cancer with diffuse bone involvement without prior calcium/vitamin D supplementations.
Uhm SJ; Hall JA; Herrington JD
J Oncol Pharm Pract; 2021 Jul; 27(5):1287-1290. PubMed ID: 33081580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
